Description

Spirovac VL5 contains a specially prepared, inactivated and adjuvanted unique strain of Leptospira borgpetersenii serovar hardjo (Type: hardjo-bovis) together with inactivated and adjuvanted cultures of L. pomona, L. grippotyphosa, L. canicola, L. icterohaemorrhagiae and Campylobacter fetus.

Approved Uses

Spirovac VL5 is for vaccination of healthy cattle, including pregnant cows and heifers, over 4 weeks of age, as an aid in preventing disease caused by the above organisms. In addition, it is especially recommended to prevent establishment of L. hardjo in the kidney, and thus shedding in the urine, for at least 12 months. Spirovac VL5 also prevents the establishment of L. hardjo in the genital tract and aids in preventing infection of the fetus.

Key Advantages
- Spirovac® VL5 protects against leptospirosis caused by L. borgpetersenii serovar hardjo (Type: hardjo-bovis).

- Spirovac VL5 prevents hardjo-bovis shedding and transmission with no detectable bacteria in kidneys or reproductive tract.

- Spirovac VL5 provides 12 month duration of immunity (DOI) against hardjo-bovis urinary shedding, which means less time and labor required, increasing peace of mind.

- Spirovac VL5 helps prevent hardjo-bovis transmission in utero and leads to more live calves.

- Spirovac VL5 is safe for use in pregnant cows, making it easy to implement whole-herd protection.

- Spirovac VL5 stimulates a robust cell-mediated immune response.

Packaging

Spirovac VL5 is available in 10 dose vials and 50 dose vials.